Title : Anti-TROVE2 Antibody Determined by Immune-Related Array May Serve as a Predictive Marker for Adalimumab Immunogenicity and Effectiveness in RA.

Pub. Date : 2021

PMID : 33763493






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Immunofluorescence assay validated that anti-TROVE2 antibody could highly predict ADAb development and poor EULAR response (AUC 0.79 and 0.89, respectively). N,n-dimethyl-4,4'-azodianiline Ro60, Y RNA binding protein Homo sapiens
2 Multivariate regression analysis proved anti-TROVE2 antibody to be an independent predictor for developing ADAb. N,n-dimethyl-4,4'-azodianiline Ro60, Y RNA binding protein Homo sapiens
3 Immune-related protein microarray and replication analysis identified anti-TROVE2 antibody as a useful biomarker for predicting ADAb development and therapeutic response in adalimumab-treated patients. N,n-dimethyl-4,4'-azodianiline Ro60, Y RNA binding protein Homo sapiens